Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
68.12
+0.90 (1.34%)
At close: May 16, 2025, 4:00 PM
68.73
+0.61 (0.90%)
After-hours: May 16, 2025, 7:42 PM EDT
Insmed Stock Forecast
Stock Price Forecast
According to 15 professional analysts, the 12-month price target for Insmed stock ranges from a low of $63 to a high of $109. The average analyst price target of $95.93 forecasts a 40.83% increase in the stock price over the next year.
Price Target: $95.93 (+40.83%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 10 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $105 | Strong Buy | Initiates | $105 | +54.14% | May 13, 2025 |
| UBS | UBS | Strong Buy Maintains $110 → $109 | Strong Buy | Maintains | $110 → $109 | +60.01% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +32.12% | Apr 22, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $92 → $96 | Strong Buy | Maintains | $92 → $96 | +40.93% | Mar 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $100 | Buy | Reiterates | $100 | +46.80% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
470.93M
from 363.71M
Increased by 29.48%
Revenue Next Year
1.02B
from 470.93M
Increased by 117.02%
EPS This Year
-5.45
from -5.57
EPS Next Year
-3.81
from -5.45
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 537.9M | 1.5B | 2.4B | ||
| Avg | 470.9M | 1.0B | 1.9B | ||
| Low | 356.7M | 790.1M | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.9% | 214.7% | 139.4% | ||
| Avg | 29.5% | 117.0% | 84.8% | ||
| Low | -1.9% | 67.8% | 40.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.86 | -1.64 | 2.91 | ||
| Avg | -5.45 | -3.81 | -0.82 | ||
| Low | -5.90 | -6.18 | -2.68 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.